Zhuhai Rundu Pharmaceutical Co Ltd Class A Total Liabilities
Zhuhai Rundu Pharmaceutical Co Ltd Class A total liabilities. Based on the latest financial reports, Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has total liabilities worth CN¥945.74 Million CNY (≈ $138.39 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
Total liabilities of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. This chart illustrates how Zhuhai Rundu Pharmaceutical Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Competitors by Total Liabilities
The table below lists competitors of Zhuhai Rundu Pharmaceutical Co Ltd Class A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hangzhou Landscape Architecture Design Institute Co Ltd
SHE:300649
|
China | CN¥402.17 Million |
|
Deep Industries Limited
NSE:DEEPINDS
|
India | Rs5.09 Billion |
|
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
|
India | Rs-12.05 Billion |
|
Soft-World International
TWO:5478
|
Taiwan | NT$9.49 Billion |
|
Vital Farms Inc
NASDAQ:VITL
|
USA | $218.43 Million |
|
Brainsway Ltd
NASDAQ:BWAY
|
USA | $42.79 Million |
|
Magnera Corp placeholder
NYSE:MAGN
|
USA | $2.82 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Zhuhai Rundu Pharmaceutical Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Zhuhai Rundu Pharmaceutical Co Ltd Class total assets.
Liquidity & Leverage Metrics
Zhuhai Rundu Pharmaceutical Co Ltd Class A Total Liabilities Ratios Explained
Zhuhai Rundu Pharmaceutical Co Ltd Class A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhuhai Rundu Pharmaceutical Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
The table below shows the annual total liabilities of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥990.19 Million ≈ $144.90 Million |
-4.93% |
| 2024-12-31 | CN¥1.04 Billion ≈ $152.41 Million |
-0.68% |
| 2023-12-31 | CN¥1.05 Billion ≈ $153.45 Million |
-3.83% |
| 2022-12-31 | CN¥1.09 Billion ≈ $159.55 Million |
+36.76% |
| 2021-12-31 | CN¥797.28 Million ≈ $116.67 Million |
+67.66% |
| 2020-12-31 | CN¥475.54 Million ≈ $69.59 Million |
+23.07% |
| 2019-12-31 | CN¥386.39 Million ≈ $56.54 Million |
+44.65% |
| 2018-12-31 | CN¥267.13 Million ≈ $39.09 Million |
+23.01% |
| 2017-12-31 | CN¥217.16 Million ≈ $31.78 Million |
-0.57% |
| 2016-12-31 | CN¥218.42 Million ≈ $31.96 Million |
+15.57% |
| 2015-12-31 | CN¥189.00 Million ≈ $27.66 Million |
+85.11% |
| 2014-12-31 | CN¥102.10 Million ≈ $14.94 Million |
-5.68% |
| 2013-12-31 | CN¥108.25 Million ≈ $15.84 Million |
+14.39% |
| 2012-12-31 | CN¥94.63 Million ≈ $13.85 Million |
+29.12% |
| 2011-12-31 | CN¥73.29 Million ≈ $10.72 Million |
-- |
About Zhuhai Rundu Pharmaceutical Co Ltd Class A
Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular, gastrointestinal, antibiotics, analgetic and antipyretics, anti-virus, endocrinology, and respiratory; and pellets for excipient, antiulcerative, diabetes … Read more